Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer.
Adenis
Antoine
A
Vanseymortier
Luc
L
Foissey
David
D
Colombel
Jean-Frédéric
JF
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003093:Colitis, Ulcerative / Q000601:surgery*; D005260:Female; D006801:Humans; D007077:Ileal Diseases / Q000139:chemically induced; D007412:Intestinal Fistula / Q000139:chemically induced; D008875:Middle Aged; D011183:Postoperative Complications / Q000139:chemically induced*; D012004:Rectal Neoplasms / Q000601:surgery*; D012008:Recurrence; D014624:Vaginal Fistula / Q000139:chemically induced
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab